ID: ALA2147347

Max Phase: Preclinical

Molecular Formula: C6H8ClNO3

Molecular Weight: 141.13

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cl.NCc1ccc(C(=O)O)o1

Standard InChI:  InChI=1S/C6H7NO3.ClH/c7-3-4-1-2-5(10-4)6(8)9;/h1-2H,3,7H2,(H,8,9);1H

Standard InChI Key:  VZBDETJVJSTWPP-UHFFFAOYSA-N

Associated Targets(non-human)

Gamma-amino-N-butyrate transaminase 192 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 141.13Molecular Weight (Monoisotopic): 141.0426AlogP: 0.44#Rotatable Bonds: 2
Polar Surface Area: 76.46Molecular Species: ACIDHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 2.95CX Basic pKa: 7.90CX LogP: -2.53CX LogD: -2.64
Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.63Np Likeness Score: -0.32

References

1. Hawker DD, Silverman RB..  (2012)  Synthesis and evaluation of novel heteroaromatic substrates of GABA aminotransferase.,  20  (19): [PMID:22944334] [10.1016/j.bmc.2012.08.009]

Source